Cosmos Health Inc. announced continued operational growth and infrastructure expansion at its pharmaceutical distribution subsidiary, Cosmofarm, in Greece. In 2025, Cosmofarm added nearly 100 new pharmacy customers, representing an approximate 20% increase in its active customer base. Annual revenue per customer rose by about 12%, while profitability per customer improved by roughly 14%, attributed to enhanced route density, optimized order execution, and increased operational leverage. The company introduced three new delivery routes within the Attica region, expanding coverage and delivery frequency. Ongoing investments in automation, including ROWA and A-frame robotic systems, are expected to support incremental annual revenue potential of approximately $40 million. A new capital investment program of around $1 million is underway to further expand robotic capacity and throughput. Management expects customer growth in 2026 to continue at similar or higher rates.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmos Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9628809-en) on January 20, 2026, and is solely responsible for the information contained therein.